GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3178 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3178 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KDR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
15.0641 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TERT |
11.9124 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2 |
11.9124 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, HSD11B2, HTR1B, HTR5A, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC |
10.401 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
10.1433 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
10.1147 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
9.6787 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
9.51332 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, KDR, KIT, MMP2, PIK3CA, PPARA, PTGS2, RORC, SRC |
9.51332 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
9.50589 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC |
8.70941 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SOAT1, SOAT2, SRC, TNKS2 |
8.70941 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, SOAT1, SOAT2 |
8.70757 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
8.65246 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.21261 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2 |
8.21261 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
8.11647 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.10096 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, TERT, XDH |
8.09992 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, KIT, MMP2, PPARA, PTGS2, SRC |
8.08873 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, PTGS2, RORC, SRC |
7.982 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
7.982 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, SRC |
7.84501 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, XDH |
7.6731 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.29669 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
7.19421 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
7.16982 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CNR1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
7.16982 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
7.11946 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HTR2A, HTR2B, HTR5A, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS2 |
7.09057 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.93566 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, KIT, PPARA, PTGS2, SRC |
6.92444 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
6.9093 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, KIT, PTGS2 |
6.73371 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, KIT, PTGS2 |
6.73371 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT |
6.67506 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC |
6.67506 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
6.67506 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
6.60394 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, TERT |
6.59908 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SOAT1, SOAT2, SRC, TERT |
6.30591 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, KDR, SRC |
6.28733 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC, TERT |
6.28733 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
6.21967 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SOAT1, SOAT2 |
6.18131 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.18131 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
6.17544 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HTR1A, SOAT1, SOAT2 |
6.17544 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC |
6.10751 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.07298 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TERT |
6.05403 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2C |
5.9932 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
5.95673 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
5.95673 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
5.89471 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.87395 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.87395 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, PIK3CA, PTGS2, RORC, SRC |
5.86214 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1 |
5.7911 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.70439 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.69416 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.64131 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.62122 |
[BP] GO:0050795 |
None
|
CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
5.62122 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, PTGS2, TERT |
5.59744 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.58568 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
5.5696 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
5.55812 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
5.53446 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
5.52869 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.49761 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, APP, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC |
5.47654 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
5.37496 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
5.36018 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.33987 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH |
5.3279 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC |
5.31676 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.30702 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.24193 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.21145 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, HTR1D, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.19155 |
[BP] GO:0007193 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.17944 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, HTR7, KIT, PPARA, RORC, SRC |
5.17944 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
5.16939 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.15064 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, PIK3CB, PTGS2, TNKS, TNKS2 |
5.09434 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SOAT1, SRC, XDH |
5.09404 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.09245 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, RORC, SRC |
5.0876 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.07695 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.03634 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.03371 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.03048 |
[BP] GO:0097746 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.00323 |
[BP] GO:0035296 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.00323 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.00323 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.00323 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.99243 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TNKS |
4.93676 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.93641 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1 |
4.90668 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.88304 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.8619 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
4.85482 |
[BP] GO:0050880 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.83274 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
4.82658 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.82285 |
[BP] GO:0035150 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.81614 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
4.80278 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC |
4.73762 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
4.7083 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.70804 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.671 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.6479 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 |
4.57754 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
4.57483 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.56665 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2, SRC, TERT |
4.56205 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.55825 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
4.50118 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
4.50036 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.49998 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
4.4891 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.47976 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, DRD2, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
4.47652 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC |
4.43124 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
4.42767 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.41819 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TNKS |
4.3894 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.38145 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.37869 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC |
4.35224 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
4.3192 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.30349 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.27601 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2 |
4.23556 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.23556 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.23556 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, KDR, KIT, PIK3CA, PPARA, PTPRS, SRC |
4.2213 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.18858 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
4.18858 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TERT |
4.16744 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC |
4.16466 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
4.15904 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC, TERT |
4.07117 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.06661 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.02212 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
4.00178 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
3.99197 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.96475 |
[BP] GO:0003008 |
None
|
AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KIT, PIK3CA, PTGS2, SOAT2, SRC |
3.87509 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.83786 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
3.83549 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.82386 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, PPARA, PTGS2, RORC, SOAT1, SRC, TERT, TNKS, TNKS2 |
3.82213 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.82073 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.79836 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, CNR2, DRD1, DRD2, DYRK1A, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.76461 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.75897 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, CNR2, DRD1, DRD2, DYRK1A, ESR1, ESR2, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.74871 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HTR5A, KDR, KIT, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC |
3.74325 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, APP, BCL2, CA2, CA7, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
3.72092 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CNR1, DNMT1, DRD2, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.70334 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
3.6945 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
3.67997 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, DRD2, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
3.67489 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.66689 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
3.66689 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
3.65462 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, MET |
3.65034 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.62531 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD2, HTR1B, HTR2A, MMP9, PTGS2 |
3.61872 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SRC |
3.6028 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.59737 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, HTR2B, KDR, KIT, MET, MMP2, MMP9, PTGS2, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT |
3.59737 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC |
3.59365 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.57681 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CNR1, CNR2, CYP19A1, DRD2, DYRK1A, ESR1, F3, FABP4, IGF1R, MET, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.57681 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, KIT, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH |
3.55244 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.54818 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.52738 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
3.52056 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DYRK1A, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.47862 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, DRD1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
3.46491 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
3.44033 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, MET, PPARA, PTGS2, RORC, SOAT1, SRC, TERT, TNKS, TNKS2 |
3.42491 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, KIT, MET, PIK3CB, PIM1, SRC |
3.42491 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
3.42491 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.40452 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
3.38799 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
3.38283 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
3.3695 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
3.33007 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.32319 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DYRK1A, ESR1, F10, F3, FLT3, FUT7, HTR1A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
3.2988 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.28195 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.25813 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.25292 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.18881 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.18681 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.17355 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.17355 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.17 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.17 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
3.1335 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, KIT, MET, PIK3CA, PIK3CB |
3.1335 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.1335 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1335 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR2C, KIT, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TERT |
3.12878 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, CYP3A4, KIT, MET, PIK3CA, PIK3CB, SOAT1, SOAT2 |
3.09966 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, PIK3CA, TNKS2 |
3.08483 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.07646 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
3.02497 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
3.02497 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.01997 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.01944 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.01604 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.01604 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.01604 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.99988 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
2.98561 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, DRD2, PTGS2 |
2.97928 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.95316 |
[BP] GO:0007267 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
2.95305 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, KIT, MMP2, MMP9, PTGS2, SRC |
2.94592 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.94406 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2 |
2.92709 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.91043 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.91043 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
2.90034 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
2.89411 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.87808 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87808 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.86983 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
2.86983 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.86962 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
2.86937 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TUBB3 |
2.85869 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, SRC, TNKS |
2.8228 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A |
2.81862 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F3, HTR2A, HTR2B, KDR, KIT, MET, MMP9, PIM1, PTGS2, SRC, TERT |
2.8149 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.80995 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F3, HTR2A, HTR2C, KDR, KIT, PIM1, PTGS2, SRC, TERT |
2.80532 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
2.79837 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
2.79126 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.75826 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
2.75626 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.73316 |
[BP] GO:0051967 |
None
|
DRD2, HTR1B, HTR2A |
2.73316 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH |
2.71986 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, PPARA, PTGS2, PTPRS |
2.71116 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, HTR1B, KDR, PTGS2, SRC |
2.71105 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
2.70616 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.69327 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.69327 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
2.68677 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.68624 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.65505 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DNMT1, DRD1, ESR1, FLT3, HTR1B, IGF1R, KIT, MMP2, PTGS2, SRC |
2.64774 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2C, KDR, KIT, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, TERT, TNKS2, XDH |
2.64593 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
2.63886 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.61496 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.61487 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.61487 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.61487 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
2.60734 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGS2, SRC |
2.58925 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.58686 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.58686 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.58686 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.58686 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.58686 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.58686 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.58686 |
[BP] GO:0023052 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
2.57928 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.57924 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, XDH |
2.57924 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
2.57708 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.56871 |
[BP] GO:0008217 |
None
|
CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 |
2.5667 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.53572 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.52356 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, HTR1B, IGF1R, MMP2, PTGS2, SRC |
2.52234 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.51983 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.4994 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.49326 |
[BP] GO:0034435 |
None
|
SOAT1, SOAT2 |
2.49326 |
[BP] GO:0034433 |
None
|
SOAT1, SOAT2 |
2.49326 |
[BP] GO:0034434 |
None
|
SOAT1, SOAT2 |
2.49326 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.49326 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49326 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.49326 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, HTR1B, HTR2C |
2.4895 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.4895 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.47183 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2, TERT |
2.44851 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, HTR2C, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPRS, SRC, TERT, TNKS2, XDH |
2.43574 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.42336 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.42279 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
2.41785 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, HTR2A, KIT, PTGS2 |
2.40736 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, DRD2, FLT3, HTR2A, HTR2B, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.40039 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.39743 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.39682 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DNMT1, DRD1, DRD2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PTPN1, SRC |
2.39427 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, ESR1, ESRRA, KIT, MMP2, PIK3CA, PIK3CB, PTPN1, PTPRS, SRC |
2.39286 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SOAT1, SRC, XDH |
2.385 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.36972 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
2.36972 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.36822 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.36453 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.35959 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.35959 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
2.3555 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.34427 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.33306 |
[BP] GO:0006952 |
defense response
|
ADORA3, ALOX15, APP, AXL, BCL2, CNR2, DRD1, HTR1A, HTR2C, KIT, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC |
2.3292 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.31368 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, HTR1B, IGF1R, MMP2, PTGS2, SRC |
2.30709 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.30709 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.30709 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.28838 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.28838 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.28421 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.28421 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, KIT, MET, PIK3CA, PIK3CB |
2.28421 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.28421 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.26955 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.26955 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, AXL, CNR2, KIT, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.26645 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MET, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2 |
2.26645 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.26422 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.26094 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
FLT3, HTR2A, HTR2B, IGF1R, KIT, PIK3CB, PTPN1, SRC |
2.25787 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.25669 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25669 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25669 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.25669 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25669 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.25669 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CNR1, CSNK2A1, DNMT1, DRD2, ESR1, ESR2, IGF1R, KDR, KIT, MET, MMP1, MMP9, PIK3CB, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.24993 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.24993 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.2441 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
CDC25B, DRD2, FLT3, HTR2A, HTR2B, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.22559 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.21756 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CNR1, CYP1A1, DRD1, ESR1, KIT, PTGS2, SRC |
2.21466 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.19859 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, PPARA, PTGS2, SRC |
2.19859 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.19859 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19859 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.19499 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.18691 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.18681 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.18681 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
2.18681 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC |
2.18313 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
FLT3, HTR2A, HTR2B, KIT, PIK3CB, PTPN1, SRC |
2.16246 |
[BP] GO:0003012 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.16246 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.16246 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.15561 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.15561 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15561 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.15304 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.11734 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.11065 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.10526 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.10412 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.10412 |
[BP] GO:0050890 |
None
|
APP, CNR1, DRD1, DRD2, HTR2A, KIT, PTGS2 |
2.09475 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.07485 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07485 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.07485 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.07485 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.07485 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.07485 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.06895 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.06895 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.06895 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, APP, CYP1B1, CYP3A4, SOAT1, SOAT2 |
2.06895 |
[BP] GO:0042632 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.06895 |
[BP] GO:0055092 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.06895 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2 |
2.04903 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.03458 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.03458 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.02764 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.02506 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, DRD1, DRD2, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
7.70795 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, PTPRS, SRC, TERT |
6.72698 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, F10, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PTGS2, PTPRS, SRC |
6.43949 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2 |
6.37338 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
6.09646 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, PTPRS, SOAT1, SOAT2, SRC |
5.43269 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F10, FLT3, HSD11B1, HSD11B2, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2 |
3.19117 |
[CC] GO:0030424 |
None
|
APP, BACE1, CA2, CNR1, DRD2, HTR2A, PTPRS, TUBB3 |
2.95 |
[CC] GO:0043005 |
None
|
APP, BACE1, CA2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, PTGS2, PTPRS, SRC, TUBB3 |
2.66486 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, HSD11B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PTPRS, SOAT1, SOAT2 |
2.65514 |
[CC] GO:0120025 |
None
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.63886 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.39427 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.34427 |
[CC] GO:0044464 |
cell part
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
2.30466 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, HSD11B1, HSD11B2, PTGS1, PTGS2, SOAT1, SOAT2 |
2.15561 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
16.9615 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3178 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3178 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.2657 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.2657 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.9108 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.642 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
12.2971 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TNKS, XDH |
12.2971 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
11.8076 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.6422 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
10.312 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA, RORC |
9.71917 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, F10, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
9.00768 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC, SOAT1, SOAT2 |
8.6304 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA, RORC |
8.58066 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA, RORC |
8.25528 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
7.88025 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA, RORC |
7.68803 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
7.62156 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
6.31211 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET |
6.28733 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET |
6.28733 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, SOAT1, SOAT2, SRC, XDH |
6.24074 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC, SOAT1, SOAT2 |
6.03658 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, TNKS |
5.71725 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.25998 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, AOX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TERT, TUBB3, XDH |
5.17944 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.13504 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.99483 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.99483 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.91842 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.91117 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, XDH |
4.74684 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.73762 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.7083 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.57483 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.47053 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
4.15837 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.04932 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.03158 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.92041 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.91067 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.83259 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, AOX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TUBB3, XDH |
3.66689 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
3.38283 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.26185 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.21746 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, DYRK1A, F10, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PTPRS, SOAT1, SOAT2, SRC, TUBB3, XDH |
3.16706 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.01604 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1 |
3.01604 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.87808 |
[MF] GO:0034736 |
None
|
SOAT1, SOAT2 |
2.87808 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87808 |
[MF] GO:0004772 |
None
|
SOAT1, SOAT2 |
2.87808 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.87808 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.87808 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC |
2.80995 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.70813 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SOAT1, SOAT2, SRC, TUBB3, XDH |
2.65505 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.61487 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MMP9, NQO2, PTGS2, TERT, XDH |
2.52979 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.49326 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.49326 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.49326 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.4895 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.39286 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.34427 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TERT |
2.28421 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25669 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.25669 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.25669 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.16246 |
[MF] GO:0050662 |
coenzyme binding
|
AOX1, HSD11B2, HSD17B1, NQO2, SOAT1, SOAT2, XDH |
2.08591 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.07485 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07485 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.06895 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.06895 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1 |
2.02764 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.02764 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.00144 |